Xeme Biopharma (United States)
- Research works
- 2 ▼ 100% vs 2013–17
- Citations
- 74 31.1 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: Xeme Biopharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Xeme Biopharma (United States) publish most on?
By volume in 2022–2025: Force Microscopy Techniques and Applications, Microtubule and mitosis dynamics and Cellular Mechanics and Interactions.
- 1 Force Microscopy Techniques and Applications Atomic and Molecular Physics, and Optics 0 works
- 2 Microtubule and mitosis dynamics Cell Biology 0 works
- 3 Cellular Mechanics and Interactions Cell Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Xeme Biopharma (United States)'s research output changed?
Output in 2018–2022 was 100% lower than in 2013–2017.
Other research institutions in Monmouth Junction
- Tris Pharma (United States)
- United Silicon Carbide (United States)
- Knite (United States)
- Provid Pharmaceuticals (United States)
- PharmaSeq (United States)
- CytoSorbents (United States)
- Nanonex (United States)
- Diamir (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.